메뉴 건너뛰기




Volumn 50, Issue 18, 2007, Pages 4316-4328

Design and synthesis of HIV-1 protease inhibitors incorporating oxazolidinones as P2/P2′ ligands in pseudosymmetric dipeptide isosteres

Author keywords

[No Author keywords available]

Indexed keywords

(HYDROXYETHYL)HYDRAZINE; AMIDE; AMPRENAVIR; ATAZANAVIR; DARUNAVIR; DIPEPTIDE; ENZYME INHIBITOR; HYDRAZINE DERIVATIVE; HYDROXYETHYLENE; HYDROXYL GROUP; INDINAVIR; LIGAND; LOPINAVIR; N [2 HYDROXY 4 [[3 METHYL 1 OXO 2 (TETRAHYDRO 2 OXO 1 PYRIMIDINYL)BUTYL]AMINO] 5 PHENYL 1 (PHENYLMETHYL)PENTYL] 2 OXO 3 PHENYLOXAZOLIDINE 5 CARBOXAMIDE; N [4 [[2 (ACETYLAMINO) 3 METHYL 1 OXOBUTYL]AMINO] 2 HYDROXY 5 PHENYL 1 (PHENYLMETHYL)PENTYL] 3 (3 ACETYLPHENYL) 2 OXOOXAZOLIDINE 5 CARBOXAMIDE; N PHENYLOXAZOLIDINONE 5 CARBOXAMIDE DERIVATIVE; NELFINAVIR; OXAZOLIDINE DERIVATIVE; OXAZOLIDINONE DERIVATIVE; PHENYLOXAZOLIDINONE DERIVATIVE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; TIPRANAVIR; UNCLASSIFIED DRUG;

EID: 34548475074     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm070284z     Document Type: Article
Times cited : (61)

References (51)
  • 5
    • 0028846226 scopus 로고
    • Crystal structure of HIV-1 protease in complex with VX-478, a potent and orally bioavailable inhibitor of the enzyme
    • Kim, E. E.; Baker, C. T.; Dwyer, M. D.; Murcko, M. A.; Rao, B. G.; Tung, R. D.; Navia, M. A. Crystal structure of HIV-1 protease in complex with VX-478, a potent and orally bioavailable inhibitor of the enzyme. J. Am. Chem. Soc. 1995, 117, 1181-1182.
    • (1995) J. Am. Chem. Soc , vol.117 , pp. 1181-1182
    • Kim, E.E.1    Baker, C.T.2    Dwyer, M.D.3    Murcko, M.A.4    Rao, B.G.5    Tung, R.D.6    Navia, M.A.7
  • 6
    • 0031788930 scopus 로고    scopus 로고
    • Sham, H. L.; Kempf, D. J.; Molla, A.; Marsh, K. C.; Kumar, G. N.; Chen, C. M.; Kati, W.; Stewart, K.; Lal, R.; Hsu, A.; Betebenner, D.; Korneyeva, M.; Vasavanonda, S.; McDonald, E.; Saldivar, A.; Wideburg, N.; Chen, X.; Niu, P.; Park, C.; Jayanti, V.; Grabowski, B.; Granneman, G. R.; Sun, E.; Japour, A. J.; Leonard, J. M.; Plattner, J. J.; Norbeck, D. W. ABT-378, a highly potent inhibitor of the human immunodeficiency virus protease. Antimicrob. Agents Chemother. 1998, 42, 3218-3224.
    • Sham, H. L.; Kempf, D. J.; Molla, A.; Marsh, K. C.; Kumar, G. N.; Chen, C. M.; Kati, W.; Stewart, K.; Lal, R.; Hsu, A.; Betebenner, D.; Korneyeva, M.; Vasavanonda, S.; McDonald, E.; Saldivar, A.; Wideburg, N.; Chen, X.; Niu, P.; Park, C.; Jayanti, V.; Grabowski, B.; Granneman, G. R.; Sun, E.; Japour, A. J.; Leonard, J. M.; Plattner, J. J.; Norbeck, D. W. ABT-378, a highly potent inhibitor of the human immunodeficiency virus protease. Antimicrob. Agents Chemother. 1998, 42, 3218-3224.
  • 8
    • 12944322516 scopus 로고    scopus 로고
    • Turner, S. R.; Strohbach, J. W.; Tommasi, R. A.; Aristoff, P. A.; Johnson, P. D.; Skulnick, H. I.; Dolak, L. A.; Seest, E. P.; Tomich, P. K.; Bohanon, M. J.; Horng, M. M.; Lynn, J. C.; Chong, K. T.; Hinshaw, R. R.; Watenpaugh, K. D.; Janakiraman, M. N.; Thaisrivongs, S. Tipranavir (PNU-140690): A potent, orally bioavailable nonpeptidic HIV protease inhibitor of the 5,6-dihydro-4-hydroxy-2-pyrone sulfonamide class. J. Med. Chem. 1998, 41, 3467-3476.
    • Turner, S. R.; Strohbach, J. W.; Tommasi, R. A.; Aristoff, P. A.; Johnson, P. D.; Skulnick, H. I.; Dolak, L. A.; Seest, E. P.; Tomich, P. K.; Bohanon, M. J.; Horng, M. M.; Lynn, J. C.; Chong, K. T.; Hinshaw, R. R.; Watenpaugh, K. D.; Janakiraman, M. N.; Thaisrivongs, S. Tipranavir (PNU-140690): A potent, orally bioavailable nonpeptidic HIV protease inhibitor of the 5,6-dihydro-4-hydroxy-2-pyrone sulfonamide class. J. Med. Chem. 1998, 41, 3467-3476.
  • 10
    • 6344231715 scopus 로고    scopus 로고
    • Structural and thermodynamic basis for the binding of TMC114, a next-generation human immunodeficiency virus type 1 protease inhibitor
    • King, N. M.; Prabu-Jeyabalan, M.; Nalivaika, E. A.; Wigerinck, P.; de Bethune, M. P.; Schiffer, C. A. Structural and thermodynamic basis for the binding of TMC114, a next-generation human immunodeficiency virus type 1 protease inhibitor. J. Virol. 2004, 78, 12012-12021.
    • (2004) J. Virol , vol.78 , pp. 12012-12021
    • King, N.M.1    Prabu-Jeyabalan, M.2    Nalivaika, E.A.3    Wigerinck, P.4    de Bethune, M.P.5    Schiffer, C.A.6
  • 12
    • 19544386471 scopus 로고    scopus 로고
    • TMC114, a novel human immunodeficiency virus type 1 protease inhibitor active against protease inhibitor-resistant viruses, including a broad range of clinical isolates
    • De Meyer, S.; Azijn, H.; Surleraux, D.; Jochmans, D.; Tahri, A.; Pauwels, R.; Wigerinck, P.; de Bethune, M. P. TMC114, a novel human immunodeficiency virus type 1 protease inhibitor active against protease inhibitor-resistant viruses, including a broad range of clinical isolates. Antimicrob. Agents Chemother. 2005, 49, 2314-2321.
    • (2005) Antimicrob. Agents Chemother , vol.49 , pp. 2314-2321
    • De Meyer, S.1    Azijn, H.2    Surleraux, D.3    Jochmans, D.4    Tahri, A.5    Pauwels, R.6    Wigerinck, P.7    de Bethune, M.P.8
  • 13
    • 0031804609 scopus 로고    scopus 로고
    • Inhibitors of HIV-1 protease: A major success of structure-assisted drug design
    • Wlodawer, A.; Vondrasek, J. Inhibitors of HIV-1 protease: A major success of structure-assisted drug design. Annu. Rev. Biophys. Biomol. Struct. 1998, 27, 249-284.
    • (1998) Annu. Rev. Biophys. Biomol. Struct , vol.27 , pp. 249-284
    • Wlodawer, A.1    Vondrasek, J.2
  • 14
    • 0035958773 scopus 로고    scopus 로고
    • Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults
    • Bartlett, J. A.; DeMasi, R.; Quinn, J.; Moxham, C.; Rousseau, F. Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults. AIDS 2001, 15, 1369-1377.
    • (2001) AIDS , vol.15 , pp. 1369-1377
    • Bartlett, J.A.1    DeMasi, R.2    Quinn, J.3    Moxham, C.4    Rousseau, F.5
  • 17
    • 1442355578 scopus 로고    scopus 로고
    • HIV drug resistance. Structural and thermodynamic basis of resistance to HIV-1 protease inhibition: Implications for inhibitor design
    • Clavel, F.; Hance, A. J. HIV drug resistance. Structural and thermodynamic basis of resistance to HIV-1 protease inhibition: Implications for inhibitor design. N. Engl. J. Med. 2004, 350, 1023-1035.
    • (2004) N. Engl. J. Med , vol.350 , pp. 1023-1035
    • Clavel, F.1    Hance, A.J.2
  • 20
    • 33646172086 scopus 로고    scopus 로고
    • Synthesis, antiviral activity, and pharmacokinetic evaluation of P3 pyridylmethyl analogs of oximinoarylsulfonyl HIV-1 protease inhibitors
    • Randolph, J. T.; Huang, P. P.; Flosi, W. J.; DeGoey, D.; Klein, L. L.; Yeung, C. M.; Flentge, C.; Sun, M.; Zhao, C.; Dekhtyar, T. Synthesis, antiviral activity, and pharmacokinetic evaluation of P3 pyridylmethyl analogs of oximinoarylsulfonyl HIV-1 protease inhibitors. Bioorg. Med. Chem. 2006, 14, 4035-4046.
    • (2006) Bioorg. Med. Chem , vol.14 , pp. 4035-4046
    • Randolph, J.T.1    Huang, P.P.2    Flosi, W.J.3    DeGoey, D.4    Klein, L.L.5    Yeung, C.M.6    Flentge, C.7    Sun, M.8    Zhao, C.9    Dekhtyar, T.10
  • 22
    • 5444247213 scopus 로고    scopus 로고
    • Combating susceptibility to drug resistance: Lessons from HIV-1 protease
    • King, N. M.; Prabu-Jeyabalan, M.; Nalivaika, E. A.; Schiffer, C. A. Combating susceptibility to drug resistance: Lessons from HIV-1 protease. Chem. Biol. 2004, 11, 1333-1338.
    • (2004) Chem. Biol , vol.11 , pp. 1333-1338
    • King, N.M.1    Prabu-Jeyabalan, M.2    Nalivaika, E.A.3    Schiffer, C.A.4
  • 23
    • 33845492104 scopus 로고    scopus 로고
    • Discovery of HIV-1 protease inhibitors with picomolar affinities incorporating N-aryl-oxazolidinone-5-carboxamides as novel P2 ligands
    • Ali, A.; Reddy, G. S. K. K.; Cao, H.; Anjum, S. G.; Nalam, M. N. L.; Schiffer, C. A.; Rana, T. M. Discovery of HIV-1 protease inhibitors with picomolar affinities incorporating N-aryl-oxazolidinone-5-carboxamides as novel P2 ligands. J. Med. Chem. 2006, 49, 7342-7356.
    • (2006) J. Med. Chem , vol.49 , pp. 7342-7356
    • Ali, A.1    Reddy, G.S.K.K.2    Cao, H.3    Anjum, S.G.4    Nalam, M.N.L.5    Schiffer, C.A.6    Rana, T.M.7
  • 25
    • 0034374764 scopus 로고    scopus 로고
    • Stoner, E. J.; Cooper, A. J.; Dickman, D. A.; Kolaczkowski, L.; Lallaman, J. E.; Liu, J. H.; Oliver-Shaffer, P. A.; Patel, K. M.; Paterson, J. B.; Plata, D. J.; Riley, D. A.; Sham, H. L.; Stengel, P. J.; Tien, J. H. J. Synthesis of HIV Protease Inhibitor ABT-378 (Lopinavir). Org. Process Res. Dev. 2000, 4, 264-269.
    • Stoner, E. J.; Cooper, A. J.; Dickman, D. A.; Kolaczkowski, L.; Lallaman, J. E.; Liu, J. H.; Oliver-Shaffer, P. A.; Patel, K. M.; Paterson, J. B.; Plata, D. J.; Riley, D. A.; Sham, H. L.; Stengel, P. J.; Tien, J. H. J. Synthesis of HIV Protease Inhibitor ABT-378 (Lopinavir). Org. Process Res. Dev. 2000, 4, 264-269.
  • 27
    • 0001271559 scopus 로고
    • Carbodiimide-mediated amide formation in a two-phase system. A high-yield and low-racemization procedure for peptide synthesis
    • Ho, G.-J.; Emerson, K. M.; Mathre, D. J.; Shuman, R. F.; Grabowski, E. J. J. Carbodiimide-mediated amide formation in a two-phase system. A high-yield and low-racemization procedure for peptide synthesis. J. Org. Chem. 1995, 60, 3569-3570.
    • (1995) J. Org. Chem , vol.60 , pp. 3569-3570
    • Ho, G.-J.1    Emerson, K.M.2    Mathre, D.J.3    Shuman, R.F.4    Grabowski, E.J.J.5
  • 31
    • 20244387096 scopus 로고    scopus 로고
    • Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments
    • Wu, T. D.; Schiffer, C. A.; Gonzales, M. J.; Taylor, J.; Kantor, R.; Chou, S.; Israelski, D.; Zolopa, A.-R.; Fessel, W. J.; Shafer, R. W. Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments. J. Virol. 2003, 77, 4836-4847.
    • (2003) J. Virol , vol.77 , pp. 4836-4847
    • Wu, T.D.1    Schiffer, C.A.2    Gonzales, M.J.3    Taylor, J.4    Kantor, R.5    Chou, S.6    Israelski, D.7    Zolopa, A.-R.8    Fessel, W.J.9    Shafer, R.W.10
  • 34
    • 0025099455 scopus 로고
    • Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer
    • Matayoshi, E. D.; Wang, G. T.; Krafft, G. A.; Erickson, J. Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer. Science 1990, 247, 954-958.
    • (1990) Science , vol.247 , pp. 954-958
    • Matayoshi, E.D.1    Wang, G.T.2    Krafft, G.A.3    Erickson, J.4
  • 35
    • 0018787723 scopus 로고
    • Evaluation of methods for estimating the dissociation constant of tight binding enzyme inhibitors
    • Greco, W. R.; Hakala, M. T. Evaluation of methods for estimating the dissociation constant of tight binding enzyme inhibitors. J. Biol. Chem. 1979, 254, 12104-12109.
    • (1979) J. Biol. Chem , vol.254 , pp. 12104-12109
    • Greco, W.R.1    Hakala, M.T.2
  • 37
    • 0037223718 scopus 로고    scopus 로고
    • Viability of a drug-resistant human immunodeficiency virus type 1 protease variant: Structural insights for better antiviral therapy
    • Prabu-Jeyabalan, M.; Nalivaika, E. A.; King, N. M.; Schiffer, C. A. Viability of a drug-resistant human immunodeficiency virus type 1 protease variant: Structural insights for better antiviral therapy. J. Virol. 2003, 77, 1306-1315.
    • (2003) J. Virol , vol.77 , pp. 1306-1315
    • Prabu-Jeyabalan, M.1    Nalivaika, E.A.2    King, N.M.3    Schiffer, C.A.4
  • 38
    • 0005839617 scopus 로고
    • Purdue University: West Lafayette, Indiana
    • Minor, W. XdisplayF, Purdue University: West Lafayette, Indiana, 1993.
    • (1993) XdisplayF
    • Minor, W.1
  • 39
    • 0031059866 scopus 로고    scopus 로고
    • Processing of X-ray diffraction data collected in oscillation mode
    • Academic Press: New York
    • Otwinowski, Z.; Minor, W.; Charles W. Carter, Jr. Processing of X-ray diffraction data collected in oscillation mode. In Methods Enzymol.; Academic Press: New York, 1997; Vol. 276, pp 307-326.
    • (1997) Methods Enzymol , vol.276 , pp. 307-326
    • Otwinowski, Z.1    Minor, W.2    Charles, W.3    Carter, J.4
  • 40
    • 0028103275 scopus 로고
    • Number 4. The CCP4suite: Programs for protein crystallography
    • Collaborative Computational Project
    • Collaborative Computational Project, Number 4. The CCP4suite: Programs for protein crystallography. Acta Crystallogr. 1994, D50, 760-763.
    • (1994) Acta Crystallogr , vol.D50 , pp. 760-763
  • 41
    • 84920325457 scopus 로고
    • An automated package for molecular replacement
    • Navaza, J. AMoRe: An automated package for molecular replacement. Acta Crystallogr. 1994, A50, 157-163.
    • (1994) Acta Crystallogr , vol.A50 , pp. 157-163
    • Navaza, J.A.1
  • 42
    • 0034283345 scopus 로고    scopus 로고
    • How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease
    • Prabu-Jeyabalan, M.; Nalivaika, E.; Schiffer, C. A. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J. Mol. Biol. 2000, 301, 1207-1220.
    • (2000) J. Mol. Biol , vol.301 , pp. 1207-1220
    • Prabu-Jeyabalan, M.1    Nalivaika, E.2    Schiffer, C.A.3
  • 43
    • 0036077402 scopus 로고    scopus 로고
    • ARP/wARP's model-building algorithms. I. The main chain
    • Morris, R. J.; Perrakis, A.; Lamzin, V. S. ARP/wARP's model-building algorithms. I. The main chain. Acta Crystallogr. 2002, D58, 968-975.
    • (2002) Acta Crystallogr , vol.D58 , pp. 968-975
    • Morris, R.J.1    Perrakis, A.2    Lamzin, V.S.3
  • 45
    • 13244281317 scopus 로고    scopus 로고
    • Model-building tools for molecular graphics
    • Emsley, P.; Cowtan, K. Coot; Model-building tools for molecular graphics. Acta Crystallogr. 2004, D60, 2126-2132.
    • (2004) Acta Crystallogr , vol.D60 , pp. 2126-2132
    • Emsley, P.1    Cowtan2    Coot, K.3
  • 46
    • 0030924992 scopus 로고    scopus 로고
    • Refinement of macromolecular structures by the maximum-likelihood method
    • Murshudov, G. N.; Vagin, A. A.; Dodson, E. J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. 1997, D53, 240-255.
    • (1997) Acta Crystallogr , vol.D53 , pp. 240-255
    • Murshudov, G.N.1    Vagin, A.A.2    Dodson, E.J.3
  • 47
    • 0001841380 scopus 로고
    • On the rigid-body motion of molecules in crystals
    • Schomaker, V.; Trueblood, K. N. On the rigid-body motion of molecules in crystals. Acta Crystallogr. 1968, B24, 63-76.
    • (1968) Acta Crystallogr , vol.B24 , pp. 63-76
    • Schomaker, V.1    Trueblood, K.N.2
  • 48
    • 0025904209 scopus 로고
    • Rigid protein motion as a model for crystallographic temperature factors
    • Kuriyan, J.; Weis, W. I. Rigid protein motion as a model for crystallographic temperature factors. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 2773-2777.
    • (1991) Proc. Natl. Acad. Sci. U.S.A , vol.88 , pp. 2773-2777
    • Kuriyan, J.1    Weis, W.I.2
  • 49
    • 34548508518 scopus 로고    scopus 로고
    • Modelling rigid-body thermal motion in macromolecular crystal structure refinement
    • IUCr: London
    • Tickle, I. J.; Moss, D. S. Modelling rigid-body thermal motion in macromolecular crystal structure refinement. In IUCr99 Computing School; IUCr: London, 1999.
    • (1999) IUCr99 Computing School
    • Tickle, I.J.1    Moss, D.S.2
  • 51
    • 0032562224 scopus 로고    scopus 로고
    • Domain flexibility in retroviral proteases: Structural implications for drug resistant mutations
    • Rose, R. B.; Craik, C. S.; Stroud, R. M. Domain flexibility in retroviral proteases: Structural implications for drug resistant mutations. Biochemistry 1998, 37, 2607-2621.
    • (1998) Biochemistry , vol.37 , pp. 2607-2621
    • Rose, R.B.1    Craik, C.S.2    Stroud, R.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.